UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------
FORM 8-K
-------------------
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 20, 2006
Date of Report (Date of earliest event reported)
-------------------
PRO-PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
-------------------
NEVADA 000-32877 04-3562325
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
7 WELLS AVENUE
NEWTON, MASSACHUSETTS
02459
(Address of Principal Executive Offices) (Zip Code)
(617) 559-0033
(Registrant's telephone number, including area code)
-------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Change in Directors or Principal Officers, Financial Statements and Exhibits
Item 5.02. Departure of Directors or Principal Officers; Election of Directors:
Appointment of Principal Officers.
On December 20, 2006, Pro-Pharmaceuticals, Inc. ("the Company") announced that
its Board of Directors appointed James T. Gourzis, M.D., Ph.D., to serve as a
member of the Board until the 2007 annual meeting of the Company's stockholders.
From 2002 to the present, Dr. Gourzis is Principal, MEDRAND Associates,
providing consulting services with respect to scientific, strategic and
regulatory considerations associated with the development of drugs and
biologics. From 1994 to 2002, Dr. Gourzis was Senior Medical Director, PAREXEL
International Corporation. From1991 to 1994, Dr. Gourzis was Vice President
Medical Affairs, Medical and Technical Research Associates, Inc. From 1981 to
1991, Dr. Gourzis was President, MEDRAND, Inc. From 1988 to 1990, he was Vice
President Medical Affairs, Gensia Pharmaceutical, Inc. and from 1986 to 1988, he
was Chief Operating Officer, Hill Top Pharmatest, Inc. Previously, Dr. Gourzis
held senior executive positions with Group Health Associates, Merrell-National
Laboratories and Schering Corporation.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
News Release of Pro-Pharmaceuticals, Inc., dated December 20, 2006.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PRO-PHARMACEUTICALS, INC.
By: /s/ David Platt
-----------------------
David Platt
Chief Executive Officer
Date: December 20, 2006
EXHIBIT INDEX
Exhibit
Number Exhibit
-------- --------------------------------------------------------------------
99.1 News Release of Pro-Pharmaceuticals, Inc., dated December 20, 2006.